Lipid changes in inflammatory bowel disease
Part of Digestive system clinical trials.
This study looks at how fats in your blood and gut lining change in inflammatory bowel disease (IBD). It might help doctors understand IBD better and could lead to better treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have inflammatory bowel disease (IBD, like Crohn's disease or ulcerative colitis).
- You are between 18 and 80 years old.
- You can agree to take part in the study.
- You are generally healthy otherwise (no severe heart, kidney, or blood pressure problems).
- You have not recently used certain immune-suppressing drugs.
- You are not pregnant.
- You have not had surgery to remove part of your colon.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether an anti-inflammatory diet can help people with inflammatory bowel disease (IBD). Researchers want to see if this diet reduces inflammation and improves symptoms.
This study follows adults with Crohn’s disease or ulcerative colitis when their treatment is changed. It collects health information and samples to better understand how treatment changes affect people over time.
This study looks at what factors help predict how inflammatory bowel disease (IBD) may progress over time. You may be able to join if you are an adult with IBD and fit one of the study groups based on whether you have used TNF-blocking medicines before.
This study looks at how diet affects inflammatory bowel disease (IBD), which includes Crohn's disease and ulcerative colitis. It may help understand if certain foods can improve symptoms.
This study looks at how common non-alcoholic fatty liver disease is in people with inflammatory bowel disease (Crohn's or colitis). Researchers want to learn more about the link between the two conditions.
This study is looking at how the immune system works in people with inflammatory bowel disease (IBD), which includes conditions like Crohn's disease and ulcerative colitis. By comparing blood or tissue samples from people with and without IBD, researchers hope to find better ways to treat the disease in the future.
Hear when a new Inflammatory Bowel Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.